IQVIA Biotech

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis	Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, end stage renal failure, kidney disorder, kidney failure, urinary system disorder	Active, not recruiting	Phase 3	2026-06-26		NCT05908084
Ixovex-1 Single Agent and Combination Therapy	Head and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasm	Recruiting	Phase 1 / Phase 2	2025-01-30		NCT06549946

Clinical trials